Search Results - "Bidollari, I."

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    1027MO ALKS 4230 monotherapy and in combination with pembrolizumab (pembro) in patients (pts) with refractory solid tumours (ARTISTRY-1)

    1027MO ALKS 4230 monotherapy and in combination with pembrolizumab (pembro) in patients (pts) with refractory solid tumours (ARTISTRY-1) by Vaishampayan, U.N., Muzaffar, J., Velcheti, V., Winer, I., Hoimes, C.J., Rosen, S.D., Spreafico, A., McDermott, D.F., Chu, Q.S-C., Dumas, O., Gilbert, L., Hirte, H., Curtis, K.K., Du, Y., Bidollari, I., Sun, L., Putiri, E., Losey, H.C., Dezube, B., Ernstoff, M.S.

    Published in Annals of oncology (01-09-2020)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Challenges of post‐authorization safety studies: Lessons learned and results of a French study of fentanyl buccal tablet

    Challenges of post‐authorization safety studies: Lessons learned and results of a French study of fentanyl buccal tablet by Gavrielov‐Yusim, Natalie, Bidollari, Ilda, Kaplan, Sigal, Bartov, Netta

    Published in Pharmacoepidemiology and drug safety (01-05-2018)
    “…Purpose Recruiting and retaining participants in real‐world studies that collect primary data are challenging. This article illustrates these challenges using…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: